Bioretec, a globally operating Finnish medical device manufacturer of biodegradable orthopaedic implant technologies, has appointed Tuukka Paavola as CFO, effective 20 January 2025. In this role, he reports to CEO Sarah van Hellenberg Hubar-Fisher and will join the company’s management team.
Paavola brings over 20 years of experience in finance, capital markets, and strategic planning. Previously, he has served as the CFO of Nightingale Health, and in multiple leadership positions at Nordea Bank. In his new role, he will oversee all financial operations, including planning, reporting, and compliance, and will play a key role in shaping the company’s long-term financial strategy.
“[Paavola] joins us at a pivotal and exciting time in our journey as a company and we look forward to his contributions in realising our goals,” said Hubar-Fisher.
Anne-Mari Matikainen, who has served as interim CFO will support the transition process until 13 February 13.
Press release: Tuukka Paavola appointed as Chief Financial Officer of Bioretec | Bioretec
